Login to Your Account

FibroGen Adds Institutions In $100M Round To Boost HIF Work

By Randall Osborne

Thursday, February 17, 2005
Selling only about 15 percent to existing investors, privately held FibroGen Inc. placed about $100 million in convertible preferred stock to advance its pipeline in a variety of programs and start more. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription